359 related articles for article (PubMed ID: 29329948)
1. NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Glasner A; Levi A; Enk J; Isaacson B; Viukov S; Orlanski S; Scope A; Neuman T; Enk CD; Hanna JH; Sexl V; Jonjic S; Seliger B; Zitvogel L; Mandelboim O
Immunity; 2018 Jan; 48(1):107-119.e4. PubMed ID: 29329948
[TBL] [Abstract][Full Text] [Related]
2. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224.
Chen CH; Li SX; Xiang LX; Mu HQ; Wang SB; Yu KY
Biochem Biophys Res Commun; 2018 Sep; 503(1):228-234. PubMed ID: 29885835
[TBL] [Abstract][Full Text] [Related]
4. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773
[TBL] [Abstract][Full Text] [Related]
5. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression.
Glasner A; Isaacson B; Viukov S; Neuman T; Friedman N; Mandelboim M; Sexl V; Hanna JH; Mandelboim O
Sci Rep; 2017 Oct; 7(1):13090. PubMed ID: 29026144
[TBL] [Abstract][Full Text] [Related]
6. Conditional ablation of NKp46+ cells using a novel Ncr1(greenCre) mouse strain: NK cells are essential for protection against pulmonary B16 metastases.
Merzoug LB; Marie S; Satoh-Takayama N; Lesjean S; Albanesi M; Luche H; Fehling HJ; Di Santo JP; Vosshenrich CA
Eur J Immunol; 2014 Nov; 44(11):3380-91. PubMed ID: 25142413
[TBL] [Abstract][Full Text] [Related]
7. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
8. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
[TBL] [Abstract][Full Text] [Related]
9. NKp46-mediated Dicer1 inactivation results in defective NK-cell differentiation and effector functions in mice.
Degouve S; Tavares A; Viel S; Walzer T; Marçais A
Eur J Immunol; 2016 Aug; 46(8):1902-11. PubMed ID: 27195970
[TBL] [Abstract][Full Text] [Related]
10. Tumor immunoediting by NKp46.
Elboim M; Gazit R; Gur C; Ghadially H; Betser-Cohen G; Mandelboim O
J Immunol; 2010 May; 184(10):5637-44. PubMed ID: 20404273
[TBL] [Abstract][Full Text] [Related]
11. NK cell development in bone marrow and liver: site matters.
Gotthardt D; Prchal-Murphy M; Seillet C; Glasner A; Mandelboim O; Carotta S; Sexl V; Putz EM
Genes Immun; 2014 Dec; 15(8):584-7. PubMed ID: 25319498
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.
Halfteck GG; Elboim M; Gur C; Achdout H; Ghadially H; Mandelboim O
J Immunol; 2009 Feb; 182(4):2221-30. PubMed ID: 19201876
[TBL] [Abstract][Full Text] [Related]
13. A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.
Van Acker A; Gronke K; Biswas A; Martens L; Saeys Y; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Matthys P; Taghon T; Vandekerckhove B; Plum J; Dunay IR; Diefenbach A; Leclercq G
Cell Rep; 2017 May; 19(7):1431-1443. PubMed ID: 28514662
[TBL] [Abstract][Full Text] [Related]
14. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
[TBL] [Abstract][Full Text] [Related]
15. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection.
Diab M; Glasner A; Isaacson B; Bar-On Y; Drori Y; Yamin R; Duev-Cohen A; Danziger O; Zamostiano R; Mandelboim M; Jonjic S; Bacharach E; Mandelboim O
Eur J Immunol; 2017 Apr; 47(4):692-703. PubMed ID: 28191644
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
17. Role of NKp46
Haspeslagh E; van Helden MJ; Deswarte K; De Prijck S; van Moorleghem J; Boon L; Hammad H; Vivier E; Lambrecht BN
EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29444897
[TBL] [Abstract][Full Text] [Related]
18. Tumour-experienced T cells promote NK cell activity through trogocytosis of NKG2D and NKp46 ligands.
Domaica CI; Fuertes MB; Rossi LE; Girart MV; Avila DE; Rabinovich GA; Zwirner NW
EMBO Rep; 2009 Aug; 10(8):908-15. PubMed ID: 19498463
[TBL] [Abstract][Full Text] [Related]
19. Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.
Berhani O; Glasner A; Kahlon S; Duev-Cohen A; Yamin R; Horwitz E; Enk J; Moshel O; Varvak A; Porgador A; Jonjic S; Mandelboim O
Eur J Immunol; 2019 Feb; 49(2):228-241. PubMed ID: 30536875
[TBL] [Abstract][Full Text] [Related]
20. The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.
Elhaik-Goldman S; Kafka D; Yossef R; Hadad U; Elkabets M; Vallon-Eberhard A; Hulihel L; Jung S; Ghadially H; Braiman A; Apte RN; Mandelboim O; Dagan R; Mizrachi-Nebenzahl Y; Porgador A
PLoS One; 2011; 6(8):e23472. PubMed ID: 21887255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
